Sean Baker Says We Have to ‘Put Our Foot Down’ to Save Movie Theaters

Netflix announced a tentative $83 billion bid to acquire Warner Bros. Discovery, prompting strong pushback from Hollywood stakeholders including the Writers Guild of America, Jane Fonda and the Teamsters who have raised antitrust and free‑speech concerns. Filmmakers warned the deal would further erode theatrical release windows in favor of streaming, and activists are calling on the DOJ and state attorneys general to scrutinize the transaction—introducing notable regulatory and reputational risk that could affect deal timing, approval and valuation.

Analysis

Market structure: Netflix buying Warner Bros. Discovery for $83B concentrates premium IP under a deep-pocketed streamer, raising Netflix's content scale and potential pricing/leverage power while compressing third-party licensing. Winners: integrated streaming incumbents (NFLX, AMZN, AAPL long-term content franchises) and passive bondholders if synergies materialize; losers: theatrical exhibitors (AMC, CNK), independent distributors, and smaller streamers facing higher content costs. Cross-asset: expect WBD credit spreads to widen near-term (200–400bp) and NFLX equity volatility to spike; USD flows into tech/media risk assets may shift, minimal commodity impact.

Risk assessment: Main tail risks are regulatory blockade or heavy divestiture remedies (30–45% probability within 90–180 days), integration failure that destroys >$10–20B of implied synergies, and financing stress raising Netflix leverage and downgrading WBD debt. Near-term (days–weeks) the key risks are litigation filings and activist/alignment leaks; medium-term (3–12 months) is DOJ/state AG outcome and talent strikes over theatrical windows; long-term is content amortization and churn dynamics.

Trade implications: Short-term equity volatility favors event-driven arb: WBD equity should trade as an M&A spread vs implied $83B value while NFLX bears near-term execution risk; options skew favors buying NFLX downside protection 3–9 month. Credit traders should watch WBD 5–7yr paper for >200bp widening to buy; exhibitors (AMC, CNK) likely structural losers over 6–24 months and are candidates for reduction/shorting.

Contrarian angles: Consensus focuses on antitrust headlines but underestimates asset reallocation upside — forced divestitures could create attractively priced standalone assets (HBO, CNN) to buy; conversely NFLX equity sell-off may be overdone if synergies cut content cost 5–10% and improve long-term margin by 200–400bps. Historical analog: AT&T/Time Warner faced DOJ resistance but closed after 9 months with mixed stock performance; watch litigation timelines as actionable signals.

Key Decisions for Investors

• Establish a 2–3% long position in WBD common stock as an event-driven arb if the market price trades >3% below the implied $83B offer value and no DOJ/state AG complaint is filed within 30 days; target hold 3–12 months and hedge market beta with SPX futures ~1:1.
• Initiate a 1–1.5% protective position against Netflix using 3–6 month NFLX puts (e.g., 5%–10% OTM) sized to cover a 15–30% downside; scale into increases in IV and trim if NFLX closes above pre-announcement levels for five consecutive sessions.
• Buy WBD 5–7yr senior bonds or enter 5yr CDS protection (size 2–4% portfolio risk) if spreads widen >200bp vs IG media peers; expected recovery of 10–25% price on deal close or refinancing over 6–12 months.
• Reduce or establish 2% short positions in theatrical exhibitors (AMC, ticker AMC; Cinemark, ticker CNK) within 7–30 days as theatrical window pressure and content consolidation weigh on box office over the next 6–24 months.
• Deploy a volatility trade: if 3-month NFLX implied vol >120% buy 9–12 month 5% OTM puts (size 0.5–1%) financed by selling 1–3 month near-ATM calls to collect premium, betting on near-term regulatory headlines causing asymmetric downside.